On October 7th and 8th in Milano (Italy) METAFORA presented its very first diagnostics test developed for the early detection of a debilitating neurometabolic disease, the GLUT1 Deficiency Syndrome (GLUT1DS). This disease needs to be diagnosed as early as possible which is almost never the case today.

The METAglut1 test was warmly welcomed by both health professionals as well as patients’ organizations from Europe and the USA.

By attending this first European event focusing on this disease, METAFORA has extended its visibility as well as widening its network of collaborators and future customers.